Skip to Content

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

We are planning system maintenance between Friday, Apr 11 at 9:00 PM CDT and Saturday, Apr 12 at 9:00 AM CDT. This will impact both web and offline transactions, including online orders, quotes, price and availability checks, and order status inquiries. We apologize for any inconvenience.

Merck
CN

Aptamer-Based Detection of Ampicillin in Urine Samples.

Antibiotics (Basel, Switzerland) (2020-10-03)
Matthew D Simmons, Lisa M Miller, Malin O Sundström, Steven Johnson
ABSTRACT

The misuse of antibiotics in health care has led to increasing levels of drug resistant infections (DRI's) occurring in the general population. Most technologies developed for the detection of DRI's typically focus on phenotyping or genotyping bacterial resistance rather than on the underlying cause and spread of DRI's; namely the misuse of antibiotics. An aptameric based assay has been developed for the monitoring of ampicillin in urine samples, for use in determining optimal antibiotic dosage and monitoring patient compliance with treatment. The fluorescently labelled aptamers were shown to perform optimally at pH 7, ideal for buffered clinical urine samples, with limits of detection as low as 20.6 nM, allowing for determination of ampicillin in urine in the clinically relevant range of concentrations (100 nM to 100 µM). As the assay requires incubation for only 1 h with a small sample volume, 50 to 150 µL, the test would fit within current healthcare pathways, simplifying the adoption of the technology.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
β-Lactamase Blend, recombinant, expressed in E. coli
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
25 μL
Estimated to ship on 2025年4月14日
Details...
¥2,257.75
100 μL
Estimated to ship on 2025年4月14日
Details...
¥4,582.18
200 μL
Estimated to ship on 2025年4月14日
Details...
¥5,503.01